Skip to main content
. 2021 Jul 28;8:837–850. doi: 10.2147/JHC.S308587

Table 2.

Risk Factors for Late HCC Recurrence

Variables (RFS) Univariate Analysis Multivariate Analysis
HR 95% CI p-value HR 95% CI p-value
aMAP Score
 ≤64.2
 64.3–68.6 2.757 1.615–4.705 <0.001 2.537 1.463–4.398 <0.001
 ≥68.7 9.691 5.792–16.213 <0.001 6.193 3.512–10.922 <0.001
Max Size (cm)
 ≤3.0 0.663 0.352–1.249 0.204 NA NA NA
 >3.0
Number
 Solitary 1.806 0.957–3.411 <0.001 2.874 1.822–4.535 <0.001
 Multiple
Ablation sessions
 1 1.827 0.964–3.460 0.064 1.469 0.562–3.836 0.433
 2
Location
 Favorable 1.806 0.957–3.411 0.068 1.788 0.683–4.683 0.237
 Unfavorable
Etiology
 HBV NA NA NA
 HCV 1.320 0.636–2.741 0.456
 Alcoholic 1.519 0.372–6.199 0.600
Antiviral Therapy
 No 0.651 0.425–0.996 0.048 0.815 0.518–1.282 0.376
 Yes
Cirrhosis
 No 5.146 1.265–20.927 0.022 3.450 0.828–14.380 0.090
 Yes
Child-Pugh class
 A 0.536 0.074–3.856 0.535 NA NA NA
 B
AFP (ng/mL)
 ≤400 0.664 0.289–1.526 0.335 NA NA NA
 >400
ALB (g/L)
 ≤35 1.697 0.688–4.188 0.251 NA NA NA
 >35
AST (U/L)
 ≤40 0.760 0.435–1.328 0.335 NA NA NA
 >40
ALT (U/L)
 ≤40 1.341 0.818–2.197 0.245 NA NA NA
 >40
γ-GT (U/L)
 ≤60 1.244 0.786–1.968 0.352 NA NA NA
 >60

Abbreviations: NA, not applicable; HBV, hepatitis B virus; HCV, hepatitis C virus; ALBI, albumin-bilirubin; AFP, alpha-fetoprotein; ALB, albumin; AST, aspartic transaminase; ALT, alanine aminotransferase; γ-GT, γ-glutamyl transpeptidase.